Recent advances in ocular graft-versus-host disease
X Cheng, R Huang, S Huang, W Fan, R Yuan… - Frontiers in …, 2023 - frontiersin.org
Ocular graft-versus-host-disease (GVHD) remains a significant clinical complication after
allogeneic hematopoietic stem cell transplantation. Impaired visual function, pain, and other …
allogeneic hematopoietic stem cell transplantation. Impaired visual function, pain, and other …
Corneal regeneration using gene therapy approaches
One of the most remarkable advancements in medical treatments of corneal diseases in
recent decades has been corneal transplantation. However, corneal transplants, including …
recent decades has been corneal transplantation. However, corneal transplants, including …
A20 ameliorates Aspergillus fumigatus keratitis by promoting autophagy and inhibiting NF-κB signaling
F Han, L Wang, L Shen, W Liu, Y Li, H Ma… - International Journal of …, 2023 - Elsevier
Fungal keratitis (FK) is a serious, potentially sight-threatening corneal infection, which is
associated with poor prognosis. A20, also called TNFAIP3, plays significant roles in the …
associated with poor prognosis. A20, also called TNFAIP3, plays significant roles in the …
Evolving therapeutic paradigms in ocular graft-versus-host disease
Graft-versus-host disease (GVHD) is a complex immune-mediated condition that arises
when donor T-cells recognize recipient antigens as foreign, which culminates to a …
when donor T-cells recognize recipient antigens as foreign, which culminates to a …
A chimeric anti-inflammatory and anti-vascularization immunomodulator prevents high-risk corneal transplantation rejection via ex vivo gene therapy
Corneal blindness affects greater than 5 million individuals, with over 180,000 corneal
transplantations (CTs) performed annually. Inhigh-risk CTs, almost all grafts are rejected …
transplantations (CTs) performed annually. Inhigh-risk CTs, almost all grafts are rejected …
AAV-mediated gene therapies for glaucoma and uveitis: are we there yet?
Glaucoma and uveitis are non-vascular ocular diseases which are among the leading
causes of blindness and visual loss. These conditions have distinct characteristics and …
causes of blindness and visual loss. These conditions have distinct characteristics and …
Developing advanced therapeutics through the study of naturally occurring immune-mediated ocular disease in domestic animals
BC Gilger - American Journal of Veterinary Research, 2022 - Am Vet Med Assoc
This review, which is part of the “Currents in One Health” series, describes the importance of
the study of immune-mediated ocular disease in the development of innovative therapeutics …
the study of immune-mediated ocular disease in the development of innovative therapeutics …
Hydrogels in Gene Delivery Techniques for Regenerative Medicine and Tissue Engineering
K Xu, Q Zhang, D Zhu, Z Jiang - Macromolecular Bioscience, 2024 - Wiley Online Library
Hydrogels are 3D networks swollen with water. They are biocompatible, strong, and
moldable and are emerging as a promising biomedical material for regenerative medicine …
moldable and are emerging as a promising biomedical material for regenerative medicine …
Long-term in vitro monitoring of AAV-transduction efficiencies in real-time with Hoechst 33342
X Hu, R Meister, J Tode, C Framme, H Fuchs - Plos one, 2024 - journals.plos.org
Adeno-associated viral transduction allows the introduction of nucleic fragments into cells
and is widely used to modulate gene expressions in vitro and in vivo. It enables the study of …
and is widely used to modulate gene expressions in vitro and in vivo. It enables the study of …
Nucleic Acid Therapeutics in Cancer Biology
P Sengupta, N Banerjee, A Dutta, M Chaudhuri… - Nucleic Acid Biology …, 2023 - Springer
Research in cancer drug development has witnessed a rapid evolution over the past
decades, which aims to develop active biological interventions and control cancer-promising …
decades, which aims to develop active biological interventions and control cancer-promising …